LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 302

Search options

  1. Article ; Online: Quantitative Proteomic Analysis Reveals apoE4-Dependent Phosphorylation of the Actin-Regulating Protein VASP.

    Cakir, Zeynep / Lord, Samuel J / Zhou, Yuan / Jang, Gwendolyn M / Polacco, Benjamin J / Eckhardt, Manon / Jimenez-Morales, David / Newton, Billy W / Orr, Adam L / Johnson, Jeffrey R / da Cruz, Alexandre / Mullins, R Dyche / Krogan, Nevan J / Mahley, Robert W / Swaney, Danielle L

    Molecular & cellular proteomics : MCP

    2023  Volume 22, Issue 5, Page(s) 100541

    Abstract: Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease. While neurons generally produce a minority of the apoE in the central nervous system, neuronal expression of apoE increases dramatically in response to stress and is ... ...

    Abstract Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer's disease. While neurons generally produce a minority of the apoE in the central nervous system, neuronal expression of apoE increases dramatically in response to stress and is sufficient to drive pathology. Currently, the molecular mechanisms of how apoE4 expression may regulate pathology are not fully understood. Here, we expand upon our previous studies measuring the impact of apoE4 on protein abundance to include the analysis of protein phosphorylation and ubiquitylation signaling in isogenic Neuro-2a cells expressing apoE3 or apoE4. ApoE4 expression resulted in a dramatic increase in vasodilator-stimulated phosphoprotein (VASP) S235 phosphorylation in a protein kinase A (PKA)-dependent manner. This phosphorylation disrupted VASP interactions with numerous actin cytoskeletal and microtubular proteins. Reduction of VASP S235 phosphorylation via PKA inhibition resulted in a significant increase in filopodia formation and neurite outgrowth in apoE4-expressing cells, exceeding levels observed in apoE3-expressing cells. Our results highlight the pronounced and diverse impact of apoE4 on multiple modes of protein regulation and identify protein targets to restore apoE4-related cytoskeletal defects.
    MeSH term(s) Actins/metabolism ; Alzheimer Disease/metabolism ; Apolipoprotein E3/genetics ; Apolipoprotein E3/metabolism ; Apolipoprotein E4/genetics ; Apolipoprotein E4/metabolism ; Apolipoproteins E/genetics ; Apolipoproteins E/metabolism ; Phosphorylation ; Proteomics ; Animals ; Mice
    Chemical Substances Actins ; Apolipoprotein E3 ; Apolipoprotein E4 ; Apolipoproteins E ; vasodilator-stimulated phosphoprotein
    Language English
    Publishing date 2023-04-04
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2075924-1
    ISSN 1535-9484 ; 1535-9476
    ISSN (online) 1535-9484
    ISSN 1535-9476
    DOI 10.1016/j.mcpro.2023.100541
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation.

    Nelson, Maxine R / Liu, Peng / Agrawal, Ayushi / Yip, Oscar / Blumenfeld, Jessica / Traglia, Michela / Kim, Min Joo / Koutsodendris, Nicole / Rao, Antara / Grone, Brian / Hao, Yanxia / Yoon, Seo Yeon / Xu, Qin / De Leon, Samuel / Choenyi, Tenzing / Thomas, Reuben / Lopera, Francisco / Quiroz, Yakeel T / Arboleda-Velasquez, Joseph F /
    Reiman, Eric M / Mahley, Robert W / Huang, Yadong

    Nature neuroscience

    2023  Volume 26, Issue 12, Page(s) 2104–2121

    Abstract: Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD), leading to earlier age of clinical onset and exacerbating pathologies. There is a critical need to identify protective targets. Recently, a rare ... ...

    Abstract Apolipoprotein E4 (APOE4) is the strongest genetic risk factor for late-onset Alzheimer's disease (LOAD), leading to earlier age of clinical onset and exacerbating pathologies. There is a critical need to identify protective targets. Recently, a rare APOE variant, APOE3-R136S (Christchurch), was found to protect against early-onset AD in a PSEN1-E280A carrier. In this study, we sought to determine if the R136S mutation also protects against APOE4-driven effects in LOAD. We generated tauopathy mouse and human iPSC-derived neuron models carrying human APOE4 with the homozygous or heterozygous R136S mutation. We found that the homozygous R136S mutation rescued APOE4-driven Tau pathology, neurodegeneration and neuroinflammation. The heterozygous R136S mutation partially protected against APOE4-driven neurodegeneration and neuroinflammation but not Tau pathology. Single-nucleus RNA sequencing revealed that the APOE4-R136S mutation increased disease-protective and diminished disease-associated cell populations in a gene dose-dependent manner. Thus, the APOE-R136S mutation protects against APOE4-driven AD pathologies, providing a target for therapeutic development against AD.
    MeSH term(s) Animals ; Humans ; Mice ; Alzheimer Disease/genetics ; Apolipoprotein E3/genetics ; Apolipoprotein E4/genetics ; Mutation/genetics ; Neuroinflammatory Diseases ; Tauopathies/genetics
    Chemical Substances Apolipoprotein E3 ; Apolipoprotein E4 ; ApoE protein, human ; Apoe protein, mouse
    Language English
    Publishing date 2023-11-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1420596-8
    ISSN 1546-1726 ; 1097-6256
    ISSN (online) 1546-1726
    ISSN 1097-6256
    DOI 10.1038/s41593-023-01480-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Neuronal Apolipoprotein E4 Expression Results in Proteome-Wide Alterations and Compromises Bioenergetic Capacity by Disrupting Mitochondrial Function.

    Orr, Adam L / Kim, Chaeyoung / Jimenez-Morales, David / Newton, Billy W / Johnson, Jeffrey R / Krogan, Nevan J / Swaney, Danielle L / Mahley, Robert W

    Journal of Alzheimer's disease : JAD

    2019  Volume 68, Issue 3, Page(s) 991–1011

    Abstract: Apolipoprotein (apo) E4, the major genetic risk factor for Alzheimer's disease (AD), alters mitochondrial function and metabolism early in AD pathogenesis. When injured or stressed, neurons increase apoE synthesis. Because of its structural difference ... ...

    Abstract Apolipoprotein (apo) E4, the major genetic risk factor for Alzheimer's disease (AD), alters mitochondrial function and metabolism early in AD pathogenesis. When injured or stressed, neurons increase apoE synthesis. Because of its structural difference from apoE3, apoE4 undergoes neuron-specific proteolysis, generating fragments that enter the cytosol, interact with mitochondria, and cause neurotoxicity. However, apoE4's effect on mitochondrial respiration and metabolism is not understood in detail. Here we used biochemical assays and proteomic profiling to more completely characterize the effects of apoE4 on mitochondrial function and cellular metabolism in Neuro-2a neuronal cells stably expressing apoE4 or apoE3. Under basal conditions, apoE4 impaired respiration and increased glycolysis, but when challenged or stressed, apoE4-expressing neurons had 50% less reserve capacity to generate ATP to meet energy requirements than apoE3-expressing neurons. ApoE4 expression also decreased the NAD+/NADH ratio and increased the levels of reactive oxygen species and mitochondrial calcium. Global proteomic profiling revealed widespread changes in mitochondrial processes in apoE4 cells, including reduced levels of numerous respiratory complex subunits and major disruptions to all detected subunits in complex V (ATP synthase). Also altered in apoE4 cells were levels of proteins related to mitochondrial endoplasmic reticulum-associated membranes, mitochondrial fusion/fission, mitochondrial protein translocation, proteases, and mitochondrial ribosomal proteins. ApoE4-induced bioenergetic deficits led to extensive metabolic rewiring, but despite numerous cellular adaptations, apoE4-expressing neurons remained vulnerable to metabolic stress. Our results provide insights into potential molecular targets of therapies to correct apoE4-associated mitochondrial dysfunction and altered cellular metabolism.
    MeSH term(s) Adenosine Triphosphate/metabolism ; Animals ; Apolipoprotein E4/metabolism ; Cell Line, Tumor ; Energy Metabolism ; Mice ; Mitochondria/metabolism ; NAD/metabolism ; Neurons/metabolism ; Proteome/metabolism ; Reactive Oxygen Species/metabolism ; Stress, Physiological ; Transcriptome
    Chemical Substances Apolipoprotein E4 ; Proteome ; Reactive Oxygen Species ; NAD (0U46U6E8UK) ; Adenosine Triphosphate (8L70Q75FXE)
    Language English
    Publishing date 2019-03-15
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-181184
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A common transcriptional mechanism involving R-loop and RNA abasic site regulates an enhancer RNA of APOE.

    Watts, Jason A / Grunseich, Christopher / Rodriguez, Yesenia / Liu, Yaojuan / Li, Dongjun / Burdick, Joshua T / Bruzel, Alan / Crouch, Robert J / Mahley, Robert W / Wilson, Samuel H / Cheung, Vivian G

    Nucleic acids research

    2022  Volume 50, Issue 21, Page(s) 12497–12514

    Abstract: ... Here, we uncovered a mechanism where RNA abasic sites in R-loops regulate transcription by pausing RNA ... of apolipoprotein E (APOE). In some human cells such as fibroblasts, AANCR is folded into an R-loop and modified ... does not form a stable R-loop as its sequence is not modified, so it is transcribed into a full-length ...

    Abstract RNA is modified by hundreds of chemical reactions and folds into innumerable shapes. However, the regulatory role of RNA sequence and structure and how dysregulation leads to diseases remain largely unknown. Here, we uncovered a mechanism where RNA abasic sites in R-loops regulate transcription by pausing RNA polymerase II. We found an enhancer RNA, AANCR, that regulates the transcription and expression of apolipoprotein E (APOE). In some human cells such as fibroblasts, AANCR is folded into an R-loop and modified by N-glycosidic cleavage; in this form, AANCR is a partially transcribed nonfunctional enhancer and APOE is not expressed. In contrast, in other cell types including hepatocytes and under stress, AANCR does not form a stable R-loop as its sequence is not modified, so it is transcribed into a full-length enhancer that promotes APOE expression. DNA sequence variants in AANCR are associated significantly with APOE expression and Alzheimer's Disease, thus AANCR is a modifier of Alzheimer's Disease. Besides AANCR, thousands of noncoding RNAs are regulated by abasic sites in R-loops. Together our data reveal the essentiality of the folding and modification of RNA in cellular regulation and demonstrate that dysregulation underlies common complex diseases such as Alzheimer's disease.
    MeSH term(s) Humans ; R-Loop Structures ; RNA/genetics ; Alzheimer Disease/genetics ; Transcription, Genetic ; Apolipoproteins E/genetics
    Chemical Substances RNA (63231-63-0) ; Apolipoproteins E
    Language English
    Publishing date 2022-12-01
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 186809-3
    ISSN 1362-4962 ; 1362-4954 ; 0301-5610 ; 0305-1048
    ISSN (online) 1362-4962 ; 1362-4954
    ISSN 0301-5610 ; 0305-1048
    DOI 10.1093/nar/gkac1107
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: The J. David Gladstone Institutes.

    Mahley, R W

    Molecular medicine (Cambridge, Mass.)

    1997  Volume 3, Issue 9, Page(s) 569–571

    MeSH term(s) Academies and Institutes ; Acquired Immunodeficiency Syndrome ; Alzheimer Disease ; California ; Cardiovascular Diseases ; Fellowships and Scholarships ; Virology
    Language English
    Publishing date 1997-09
    Publishing country England
    Document type Journal Article
    ZDB-ID 1283676-x
    ISSN 1076-1551
    ISSN 1076-1551
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.

    Mahley, R W / Huang, Y

    Acta neurologica Scandinavica. Supplementum

    2006  Volume 185, Page(s) 8–14

    Abstract: The unique structural and biophysical features of apolipoprotein (apo) E4 - domain interaction and molten globule formation - have been correlated with the detrimental effects of apoE4 in neuropathology. Two examples of how the structure of apoE4 ... ...

    Abstract The unique structural and biophysical features of apolipoprotein (apo) E4 - domain interaction and molten globule formation - have been correlated with the detrimental effects of apoE4 in neuropathology. Two examples of how the structure of apoE4 determines the pathological outcome in neurons include apoE4 potentiation of amyloid beta-induced lysosomal leakage and apoptosis and the proteolytic cleavage of apoE synthesized by neurons. Thus, a new therapeutic target is to identify small molecules to modulate the inherent neuropathological structure of apoE4, i.e. to prevent domain interaction and to convert apoE4 to an apoE3-like molecule. A second therapeutic target is to inhibit the apoE-cleaving enzyme. This would prevent the generation of the reactive carboxyl-terminal fragments of apoE that enter the cytosol, disrupt the cytoskeleton, and cause neurodegeneration. ApoE4 is more susceptible than apoE3 to proteolytic cleavage and is thus more likely to cause detrimental effects in the central nervous system. It is predictable that apoE4 acts through various pathways to cause cognitive decline and neurodegeneration.
    MeSH term(s) Alzheimer Disease/etiology ; Apolipoprotein E4 ; Apolipoproteins E/physiology ; Apoptosis/physiology ; Humans ; Lysosomes/physiology ; Neurodegenerative Diseases/etiology ; Neurons/physiology ; Protein Conformation
    Chemical Substances Apolipoprotein E4 ; Apolipoproteins E
    Language English
    Publishing date 2006
    Publishing country Denmark
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1956-2
    ISSN 0065-1427
    ISSN 0065-1427
    DOI 10.1111/j.1600-0404.2006.00679.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Heparan sulfate proteoglycan/low density lipoprotein receptor-related protein pathway involved in type III hyperlipoproteinemia and Alzheimer's disease.

    Mahley, R W

    Israel journal of medical sciences

    1996  Volume 32, Issue 6, Page(s) 414–429

    Abstract: The heparan sulfate proteoglycan (HSPG)/low density lipoprotein (LDL) receptor-related protein (LRP) pathway plays a critical role in apolipoprotein (apo) E-containing lipoprotein metabolism in hepatocytes and other cells, including neurons. In this ... ...

    Abstract The heparan sulfate proteoglycan (HSPG)/low density lipoprotein (LDL) receptor-related protein (LRP) pathway plays a critical role in apolipoprotein (apo) E-containing lipoprotein metabolism in hepatocytes and other cells, including neurons. In this review, it will be shown that the HSPG sequestration step (i.e., the recruitment and trapping of remnant lipoproteins in the space of Disse in the liver) is an important component of remnant metabolism mediated by apo-E. In vitro studies indicate that the apo-E-containing lipoproteins must first interact with HSPG; only then does the LRP mediate lipoprotein uptake. The differential interaction of apo-EIII and the various mutant forms of apo-E with this pathway before internalization appears to be one factor that modulates the expression of recessive versus dominant type III hyperlipoproteinemia. Furthermore, it is now apparent that the HSPG/LRP pathway is involved in the delivery of apo-E to neurons, where apo-E alters neurite growth and cytoskeletal activity in these cells. Specifically, apo-EIV, which has been associated with the pathogenesis of Alzheimer's disease, inhibits neurite extension and microtubule formation subsequent to the interaction of apo-EIV with the HSPG/LRP pathway.
    MeSH term(s) Alzheimer Disease/metabolism ; Apolipoproteins E/metabolism ; Apolipoproteins E/physiology ; Heparan Sulfate Proteoglycans ; Heparitin Sulfate/metabolism ; Humans ; Hyperlipidemias/genetics ; Hyperlipoproteinemia Type III/metabolism ; Liver/metabolism ; Proteoglycans/metabolism ; Receptors, LDL/metabolism
    Chemical Substances Apolipoproteins E ; Heparan Sulfate Proteoglycans ; Proteoglycans ; Receptors, LDL ; Heparitin Sulfate (9050-30-0)
    Language English
    Publishing date 1996-06
    Publishing country Israel
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 219691-8
    ISSN 0021-2180
    ISSN 0021-2180
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Apolipoprotein E: far more than a lipid transport protein.

    Mahley, R W / Rall, S C

    Annual review of genomics and human genetics

    2000  Volume 1, Page(s) 507–537

    Abstract: First recognized as a major determinant in lipoprotein metabolism and cardiovascular disease, apolipoprotein (apo) E has emerged as an important molecule in several biological processes not directly related to its lipid transport function, including ... ...

    Abstract First recognized as a major determinant in lipoprotein metabolism and cardiovascular disease, apolipoprotein (apo) E has emerged as an important molecule in several biological processes not directly related to its lipid transport function, including Alzheimer's disease and cognitive function, immunoregulation, and possibly even infectious diseases. ApoE is a polymorphic protein arising from three alleles at a single gene locus. The three major isoforms, apoE4, apoE3, and apoE2, differ from one another only by single amino acid substitutions, yet these changes have profound functional consequences at both the cellular and molecular levels. ApoE3 seems to be the normal isoform in all known functions, while apoE4 and apoE2 can each be dysfunctional. Isoform (allele)-specific effects include the association of apoE2 with the genetic disorder type III hyperlipoproteinemia and with both increased and decreased risk for atherosclerosis and the association of apoE4 with increased risk for both atherosclerosis and Alzheimer's disease, impaired cognitive function, and reduced neurite outgrowth; isoform-specific differences in cellular signaling events may also exist. Functional differences in the apoE isoforms that affect (or did affect) survival before the reproductive years probably account, at least in part, for the allele frequencies of the present day.
    MeSH term(s) Alleles ; Animals ; Apolipoproteins E/chemistry ; Apolipoproteins E/genetics ; Apolipoproteins E/metabolism ; Arteriosclerosis/etiology ; Arteriosclerosis/genetics ; Biological Transport, Active ; Communicable Diseases/etiology ; Communicable Diseases/genetics ; Female ; Heart Diseases/etiology ; Heart Diseases/genetics ; Humans ; Hyperlipoproteinemia Type III/genetics ; Hyperlipoproteinemia Type III/metabolism ; Immunity/genetics ; Lipid Metabolism ; Lipoproteins/metabolism ; Male ; Models, Molecular ; Neurobiology ; Phenotype ; Polymorphism, Genetic ; Protein Isoforms/chemistry ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; Reproduction/genetics ; Risk Factors
    Chemical Substances Apolipoproteins E ; Lipoproteins ; Protein Isoforms
    Language English
    Publishing date 2000
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 2037670-4
    ISSN 1545-293X ; 1527-8204
    ISSN (online) 1545-293X
    ISSN 1527-8204
    DOI 10.1146/annurev.genom.1.1.507
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Is epsilon4 the ancestral human apoE allele?

    Mahley, R W / Rall, S C

    Neurobiology of aging

    1999  Volume 20, Issue 4, Page(s) 429–430

    MeSH term(s) Animals ; Apolipoprotein E4 ; Apolipoproteins E/genetics ; Evolution, Molecular ; Female ; Humans ; Male
    Chemical Substances Apolipoprotein E4 ; Apolipoproteins E
    Language English
    Publishing date 1999-07
    Publishing country United States
    Document type Comment ; Journal Article ; Review
    ZDB-ID 604505-4
    ISSN 1558-1497 ; 0197-4580
    ISSN (online) 1558-1497
    ISSN 0197-4580
    DOI 10.1016/s0197-4580(99)00081-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

    Mahley, R W

    Science (New York, N.Y.)

    1988  Volume 240, Issue 4852, Page(s) 622–630

    Abstract: Apolipoprotein E is a plasma protein that serves as a ligand for low density lipoprotein receptors and, through its interaction with these receptors, participates in the transport of cholesterol and other lipids among various cells of the body. A mutant ... ...

    Abstract Apolipoprotein E is a plasma protein that serves as a ligand for low density lipoprotein receptors and, through its interaction with these receptors, participates in the transport of cholesterol and other lipids among various cells of the body. A mutant form of apolipoprotein E that is defective in binding to low density lipoprotein receptors is associated with familial type III hyperlipoproteinemia, a genetic disorder characterized by elevated plasma cholesterol levels and accelerated coronary artery disease. Apolipoprotein E is synthesized in various organs, including liver, brain, spleen, and kidney, and is present in high concentrations in interstitial fluid, where it appears to participate in cholesterol redistribution from cells with excess cholesterol to those requiring cholesterol. Apolipo-protein E also appears to be involved in the repair response to tissue injury; for example, markedly increased amounts of apolipoprotein E are found at sites of peripheral nerve injury and regeneration. Other functions of apolipoprotein E, unrelated to lipid transport, are becoming known, including immunoregulation and modulation of cell growth and differentiation.
    MeSH term(s) Amino Acid Sequence ; Apolipoproteins E/genetics ; Apolipoproteins E/physiology ; Biological Transport ; Cholesterol/metabolism ; Gene Expression Regulation ; Humans ; Hyperlipoproteinemia Type III/genetics ; Hyperlipoproteinemia Type III/metabolism ; Immunity ; Lipid Metabolism ; Molecular Sequence Data ; Polymorphism, Genetic ; Protein Conformation ; Receptors, LDL/metabolism
    Chemical Substances Apolipoproteins E ; Receptors, LDL ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 1988-04-29
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 128410-1
    ISSN 1095-9203 ; 0036-8075
    ISSN (online) 1095-9203
    ISSN 0036-8075
    DOI 10.1126/science.3283935
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top